We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plant Health Care Plc | LSE:PHC | London | Ordinary Share | GB00B01JC540 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.09 | 2.43% | 3.80 | 3.80 | 3.84 | 3.80 | 3.80 | 3.80 | 99,415 | 16:35:23 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pesticides, Agric Chems, Nec | 11.77M | -9.48M | -0.0278 | -1.37 | 12.98M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/7/2022 22:17 | Who knows, makes the time, doesn't expect it to happen!The 2023 crop is already underway in this great producer of Goias. No matter the variety of sugarcane, H2COPLA is ensuring the full development of the plant in the pursuit of best productivity.In April, H2COPLA was applied to the planting groove. We can already check the differences in appearance in the two varieties, RB 86 1816 and RB 96 6928.In the areas with H2COPLA we have more complete and closed streets, with better health and vigor plants, unlike what we see in the witness areas (Producer Standard).With Anderson Rovari and Dennys Micky Martins Lima, CTV of @coplacana - Pride of Agro, branch of Jataí, Goiás.H2COPLA can be applied to the seedling nursery, in the planting groove, in the cutting of the base, in the initial foliar or in pre-harvest. Always bringing excellent return on investment!@plant_ph | oapknob1 | |
07/7/2022 22:15 | Brasil.First sales of H2COPLA at Citrus Culture in São Paulo!It is with great satisfaction that we announce the first sales of H2COPLA for the culture of Citrus, under the guidance of our DM Jhonatan Henrique and his colleague Alex Bazzo, CTV of @ Coplacana - Pride of Agro, Iracemápolis branch.Harpin Protein (H2COPLA) brings various benefits to Citrus culture: improves root and vegetative development of the plant, homogeneity of flowering, and adhesion of flowers and fruits. Thus, it enables the plant to produce larger fruits, with higher concentration of sugars, as well as increasing fruit retention in the tree in pre-harvest and the durability of the fruits in post-harvest, representing increased productivity.A great challenge! These early customers have a very high expectation with respect to the product's benefits over Greening, or Huanglongbing (HLB), which is known, one of the most feared illnesses among citrus growers worldwide. Caused by the bacteria Candidatus liberibacter spp, it causes branch feces, dryness and death. The fruits show irregular ripening, reduction in size, deformation and intense fall.We all want to see the benefits that the application will bring by reducing the impact that Greening has brought on Paulist citrus farming. Let's keep it up!If you're also a citrus producer, try H2COPLA and feel the increased productivity in your orchard. The first application of the cycle occurs after harvest, in pre-blooming.Contact the @coplacana branch - Agro Pride closest to you for more information.H2COPLA, the ultimate ally of the producer!It's @Plant Health Care Brazil #breakingproductivit | oapknob1 | |
28/6/2022 09:08 | You believe it ? | oapknob1 | |
22/6/2022 21:16 | There a write up on LSE from a poster called BOTs. | pretax2 | |
22/6/2022 14:19 | Anyone make the AGM?? I did not what with the tube strikes and I had a couple of webinars. I see about 60pc voter turnout which is high for an AIM company but what I would expect given their shareholder base. Heaven knows why 23pc voted against the AR and accounts | cerrito | |
16/6/2022 22:36 | Just love those largeish trades being reported well after the close. Why not report them on time? | pretax2 | |
10/6/2022 07:18 | Half year trading update last year was 26th July. | oapknob1 | |
01/6/2022 15:28 | There's your answer OAPK. Dr Richards buys back. True to his word - I like that. | pretax2 | |
29/5/2022 17:33 | https://www.bio.org/ | oapknob1 | |
27/5/2022 23:37 | Has Dr Richards had his shares bought back after the clerical error sale ? | oapknob1 | |
25/5/2022 18:23 | Spreadex buying now. In, out, in, out. Not compalining, up 6% | pretax2 | |
23/5/2022 07:51 | PHC's revenue from sales of Saori to Nutrien is expected to exceed US$750k in the first half of 2022, growing to more than US$5m by 2025.-- Nutrien expects to treat approximately 150,000 hectares of soybeans in 2022, expanding to more than one million hectares by 2025.-- The Total Addressable Market for Saori in Brazil in 2022 is estimated at 40 million hectares of soybean fields.-- Saori-treated fields were healthier and more robust, with lower incidence of disease compared to untreated fields. | oapknob1 | |
16/5/2022 09:48 | The next launch will be PHC279 in the USA; we anticipate regulatory approval in the second half of 2022 and are making detailed plans with our partner Wilbur-Ellis to launch before the end of the year. We have submitted PHC949 for registration in the USA and anticipate that this will be launched in 2023, | oapknob1 | |
16/5/2022 08:55 | pretax - they are positive in the commercial business - only (nice spin and use of words - definition of the word commercial business is not an accounting term I think) - not as a whole - eg old harpin as the main driver. and I do not know how much impact did destocking have on the profitability... growth rate is at cca 30 % total loss is (at the end of it all) huge to my standards - regarding the size of the operation. growers are adopting the product - but is is on "experimental" basis - one has to get used to the huge land numbers in agriculture. few 10o k ha is not a lot for the real impact on the business each product costs from 3 -10 mio to gain full traction and is throwing off cash - but with each sequential product costing less and less that is in general how I do see things - might be wrong | kaos3 | |
16/5/2022 08:27 | Spreadex cleared out? | oapknob1 | |
16/5/2022 08:15 | Kaos Did you see the presentation? Revenues are up, this year the company’s become profitable. Growers are clearly adopting the products. Furthermore after years of development, requiring investor input, the company can now move forwards without investment money growing organically for the first time. Yes, growth will start slowly, but this is the time to buy if you want to get in at a good share price in my opinion. The rest require a little patience. I have time, others don’t. We’re not all the same us investors. | pretax2 | |
16/5/2022 07:26 | growers (farmers) tend to be extremely conservative and even when things work well it takes years to fully adopt the product into the regular use growers are bombarded with the next big thing - and they all promise to improve growth by x %. poor farmers who must make a choice each year several times at each production turn. so by using all the next wonder products - where does he get lol - it is a jungle and for a product to become standard is a looong process at very low probability - even if it is performing as on the label imho - it would be very good it "bio plant vaccine" would be an obligatory product if used for BIO certification of the end product ..... | kaos3 | |
16/5/2022 07:13 | You are entitled to your opinion.good luck elsewhere. | pretax2 | |
16/5/2022 06:58 | I'm with Ceritto here, this is currently univestable. Clear as mud and obviously intentionally so! | my retirement fund | |
16/5/2022 06:57 | Sounded very positive in Investor presentation | davemac3 | |
16/5/2022 06:44 | If the products are as good as the trials suggest, growers will start to adopt them (especially with fertiliser prices doubling). There ought to be a snowball effect. Better to be in at the bottom of an exponential curve I suppose. | pretax2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions